Skip to main content

FDA recall, , Moderate risk

Sun Pharmaceutical Sumatriptan and Naproxen Sodium Tablets

Sumatriptan and naproxen sodium tablets failed a 12-month test of how the medicine dissolves.

What to do

Check yours

If a code on your package is listed below:

  1. Don't stop taking it without talking to your pharmacist or doctor; ask them whether your lot is recalled.

Typical advice for a recalled medicine; the FDA notice gives no product-specific instructions.

What happened

Sun Pharmaceutical Industries Inc., of Princeton, New Jersey, is recalling Sumatriptan and Naproxen Sodium Tablets. Testing during stability checks found that the tablets did not meet the quality limits the product must meet. The problem is with how the medicine dissolves, which is the step that lets the body take it in. The company started the recall on its own.

Two bottle versions are affected. One is labeled with the Northstar Healthcase Holdings Ltd. name and includes 3,453 bottles. The other is labeled Sun Pharma and includes 10,296 bottles. Both are 9-count bottles. Customers were told by letter, and the product was distributed nationwide within the U.S. The company began the recall on October 27, 2026, and the FDA classified it on November 18, 2026.

Is yours affected?

Match your product and all the details in one listed combination.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Sumatriptan and Naproxen Sodium Tablets

    Strength
    85 mg
    1. NDC
      • 16714-891-01
      Lot code
      • DNG0559A
      Recall number
      D-0187-2027
    2. NDC
      • 47335-410-22
      Lot code
      • DNG0559B
      Recall number
      D-0186-2027

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

Distributed nationwide.

Recalled by
Sun Pharmaceutical Industries IncPrinceton, New Jersey
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100207
Recall numbers
D-0186-2027 to D-0187-2027
Recall type
Started by the company
How the company first told customers
Letter

All recalls from Sun Pharmaceutical Industries Inc

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. SUN PHARMACEUTICAL INDUSTRIES INC began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)

  3. Added to Recall Canary

Summary by Recall Canary, written with AI · summary updated Nov 20, 2026 · Official source: U.S. Food and Drug Administration (opens in a new tab) recall · cite: “Sun Pharmaceutical Sumatriptan and Naproxen Sodium Tablets Recall.” Recall Canary. https://recallcanary.com/recall/fda/sun-pharmaceutical-industries-sumatriptan-and-naproxen.